A therapeutic approach to pantothenate kinase associated neurodegeneration: a pilot study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
A therapeutic approach to pantothenate kinase associated neurodegeneration: a pilot study ; volume:19 ; number:1 ; day:28 ; month:11 ; year:2024 ; pages:1-16 ; date:12.2024
Orphanet journal of rare diseases ; 19, Heft 1 (28.11.2024), 1-16, 12.2024
- Urheber
-
Pereira, Alessandra
Fischinger Moura de Souza, Carolina
Álvarez-Córdoba, Mónica
Reche-López, Diana
Sánchez-Alcázar, José Antonio
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13023-024-03453-x
- URN
-
urn:nbn:de:101:1-2502132142549.569599502576
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pereira, Alessandra
- Fischinger Moura de Souza, Carolina
- Álvarez-Córdoba, Mónica
- Reche-López, Diana
- Sánchez-Alcázar, José Antonio
- SpringerLink (Online service)
Ähnliche Objekte (12)
A therapeutic approach to pantothenate kinase associated neurodegeneration
Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
Resting state networks alteration in pantothenate-kinase associated neurodegeneration (PKAN)
Case report: MR spectroscopy in pantothenate kinase-2 associated neurodegeneration
Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration
Down regulation of the expression of mitochondrial phosphopantetheinyl-proteins in pantothenate kinase-associated neurodegeneration: pathophysiological consequences and therapeutic perspectives
Genetic mutation spectrum of pantothenate kinase-associated neurodegeneration expanded by breakpoint sequencing in pantothenate kinase 2 gene
Neurodegeneration in SCA14 is associated with increased PKCγ kinase activity, mislocalization and aggregation
Therapeutic kinase inhibitors
Pilot trial on the efficacy and safety of pantethine in children with pantothenate kinase-associated neurodegeneration: a single-arm, open-label study
Patient and caregiver experiences with pantothenate kinase-associated neurodegeneration (PKAN): results from a patient community survey
A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies
A therapeutic approach to pantothenate kinase associated neurodegeneration
Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
Resting state networks alteration in pantothenate-kinase associated neurodegeneration (PKAN)
Case report: MR spectroscopy in pantothenate kinase-2 associated neurodegeneration
Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration
Down regulation of the expression of mitochondrial phosphopantetheinyl-proteins in pantothenate kinase-associated neurodegeneration: pathophysiological consequences and therapeutic perspectives
Genetic mutation spectrum of pantothenate kinase-associated neurodegeneration expanded by breakpoint sequencing in pantothenate kinase 2 gene
Neurodegeneration in SCA14 is associated with increased PKCγ kinase activity, mislocalization and aggregation
Therapeutic kinase inhibitors
Pilot trial on the efficacy and safety of pantethine in children with pantothenate kinase-associated neurodegeneration: a single-arm, open-label study
Patient and caregiver experiences with pantothenate kinase-associated neurodegeneration (PKAN): results from a patient community survey
A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies
A therapeutic approach to pantothenate kinase associated neurodegeneration
Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
Resting state networks alteration in pantothenate-kinase associated neurodegeneration (PKAN)
Case report: MR spectroscopy in pantothenate kinase-2 associated neurodegeneration
Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration
Down regulation of the expression of mitochondrial phosphopantetheinyl-proteins in pantothenate kinase-associated neurodegeneration: pathophysiological consequences and therapeutic perspectives
Genetic mutation spectrum of pantothenate kinase-associated neurodegeneration expanded by breakpoint sequencing in pantothenate kinase 2 gene
Neurodegeneration in SCA14 is associated with increased PKCγ kinase activity, mislocalization and aggregation
Therapeutic kinase inhibitors
Pilot trial on the efficacy and safety of pantethine in children with pantothenate kinase-associated neurodegeneration: a single-arm, open-label study
Patient and caregiver experiences with pantothenate kinase-associated neurodegeneration (PKAN): results from a patient community survey